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Background
The induction of a protective immune response against
HIV remains elusive. In the majority of new HIV infec-
tions, virus traverses the mucosal barrier. A rapid and dra-
matic depletion of CD4+ T cells occurs in the gastro-
intestinal tract accompanied by active HIV replication.
The Rhesus macaque/SIV model recapitulates mucosal
transmission and pathogenesis, thus offering a means for
a much-needed comprehensive surveillance of the innate
and adaptive mucosal immune response during pre- and
post-vaccination, and challenge. In preparation for pre-
clinical studies we used mucosal tissues isolated from SIV-
infected and uninfected Rhesus macaques to develop an
integrated methodology to characterize by confocal
immunofluorescence microscopy the gut associated lym-
phoid tissue (GALT), virus-specific immune responses
and tissue architecture.
Methods
Necropsies or biopsies of duodenum, ileum and rectum
were isolated from SIV-E660 infected or uninfected
macaques. Tissues were fixed and cryopreserved embed-
ded in OCT (optimum cutting temperature). Tissue sec-
tions 8 μm thick were blocked and incubated with
fluorochrome labeled antibodies targeting B and T-lym-
phocytes, natural killer cells, myeloid and plasmacytoid
dendritic cells and immunoglobulins. SIV specific HLA-
restricted mucosal T cell responses were monitored with
fluorochrome labeled epitope specific tetramers.
Results
Data describing anatomical distribution of the different
components of the adaptive and innate immune
responses will be presented; emphasizing differences
between infected and uninfected macaques.
Conclusion
These procedures will be included in upcoming preclini-
cal protocols aiming to study tropism and immunogenic-
ity of novel HIV vaccine candidates delivered by
replicating viral vectors with mucosal tropism. Our meth-
odology was developed using cross-reacting antibodies
raised against human proteins yielding a system easily
adaptable to human trials, in anticipation of clinical stud-
ies where mucosal immune responses are required for
protection.
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